Physician

John K Bartnik, M.D.

According to 2025 Medicare claims, John Bartnik, M.D. (NPI: 1740211275) practices hematology/oncology in the Saginaw, MI market, with the plurality of this provider's patient population coming from Saginaw, MI. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY ASSOCIATES OF SAGINAW VALLEY PC (NPI: 1366472169; TIN: 383553403) and primary practice location at 48604-9533. Bartnik is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), Mosaic ACO (ACO ID: A5033), Aledade 155 National MSSP (ACO ID: A5358), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Bartnik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 416 traditional Medicare patients, billed 64,707 HCPCS/CPT codes, and received $1,150,484 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,410 prescription claims across 303 beneficiaries totaling $5,967,607 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 41 claims. Open Payments data shows 29 records totaling $715. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $2,458,768 to $1,150,484. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2015 Medicare payment: $2,458,768 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,166,412 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,449,876 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,859,185 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,473,619 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,640,059 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,994,776 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,755,092 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,779,034 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,150,484 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015917175,913$2,458,768
20161,092187,381$2,166,412
2017962158,703$2,449,876
2018803175,830$2,859,185
2019773143,798$2,473,619
2020636123,588$2,640,059
2021575123,037$1,994,776
2022531100,730$1,755,092
202349386,692$1,779,034
202441664,707$1,150,484

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.4M$6.8M2015 Drug cost: $3,653,188 (USD; Tot_Drug_Cst)2016 Drug cost: $4,977,417 (USD; Tot_Drug_Cst)2017 Drug cost: $5,402,640 (USD; Tot_Drug_Cst)2018 Drug cost: $6,116,945 (USD; Tot_Drug_Cst)2019 Drug cost: $5,109,419 (USD; Tot_Drug_Cst)2020 Drug cost: $6,388,844 (USD; Tot_Drug_Cst)2021 Drug cost: $6,546,017 (USD; Tot_Drug_Cst)2022 Drug cost: $6,849,239 (USD; Tot_Drug_Cst)2023 Drug cost: $4,975,751 (USD; Tot_Drug_Cst)2024 Drug cost: $5,967,607 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153732,286$3,653,188
20164582,539$4,977,417
20174272,366$5,402,640
20184082,320$6,116,945
20193641,832$5,109,419
20203341,814$6,388,844
20213211,574$6,546,017
20223481,555$6,849,239
20233221,440$4,975,751
20243031,410$5,967,607

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$12K$25K2015 Medicare payment: $24,819 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $9,635 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $12,339 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $10,134 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $8,352 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,830 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201583373$24,819
201661176$9,635
20171176$12,339
20181177$10,134
2019N/R106$8,352
2020N/R41$2,830
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more5454$115
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more251450$92
80053Blood test, comprehensive group of blood chemicals117232$10
36415Insertion of needle into vein for collection of blood sample109213$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count143393$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide571,397$856,092
PomalystPomalidomide34952$767,374
XtandiEnzalutamide481,440$627,276
IbrancePalbociclib391,092$599,728
LenalidomideLenalidomide531,302$573,557

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$715Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John K. Bartnik, M.D.?

Tedicare shows public-source Medicare data for John K. Bartnik, M.D. (NPI 1740211275), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John K. Bartnik, M.D. have ACO affiliation data?

John K. Bartnik, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Mosaic ACO (MSSP, ACO ID A5033), Aledade 155 National MSSP (MSSP, ACO ID A5358), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to John K. Bartnik, M.D.?

John K. Bartnik, M.D. is linked to ONCOLOGY HEMATOLOGY ASSOCIATES OF SAGINAW VALLEY PC (billing NPI 1366472169) in the available physician profile data.

Does John K. Bartnik, M.D. have Open Payments data?

John K. Bartnik, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.